Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05074524 · ClinicalTrials.gov registry record · NA
Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings
A NA study of Opioid Use Disorder and Transcranial Magnetic Stimulation, sponsored by University of Nevada, Las Vegas.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05074524: Completed NA study of Opioid Use Disorder and Transcranial Magnetic Stimulation, sponsored by University of Nevada, Las Vegas.
NCT05074524 is a NA study of Opioid Use Disorder and Transcranial Magnetic Stimulation that has completed, run by University of Nevada, Las Vegas. The registered enrollment target is 24 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05074524, a NA study of Opioid Use Disorder and Transcranial Magnetic Stimulation, has completed, sponsored by University of Nevada, Las Vegas.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to test the effect of repetitive transcranial magnetic stimulation (rTMS) on opioid cravings among adult patients with Opioid Use Disorder.
Primary Outcome
This standardized questionnaire measures cravings for opioids. This scale includes a total of 13 items. Scoring is based on a 1-7 likert scale for each item. Specific items are assigned to one of three domains: desire, negative reinforcement, and control. A higher score indicates higher level of cravings. A lower score indicates a lesser level of opioid cravings, which is a better outcome. The primary outcome measure will be measured at various time points throughout the study to assess a change
Conditions Studied
Interventions
- DEVICE Repetitive Transcranial Magnetic Stimulation
- DEVICE Sham Repetitive Transcranial Magnetic Stimulation
Study Locations (1)
Nevada
- University of Nevada, Las Vegas - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-10-06 |
| Est. Completion | 2022-01-24 |
| Phase | NA |
What the finished NCT05074524 record still lists
NCT05074524 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Repetitive Transcranial Magnetic Stimulation is the first listed.
NCT05074524 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT05074524 about?
NCT05074524 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings". The purpose of this research study is to test the effect of repetitive transcranial magnetic stimulation (rTMS) on opioid cravings among adult patients with Opioid Use Disorder.
What is the current status of trial NCT05074524?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2021-10-06. Estimated completion is 2022-01-24.
What conditions does trial NCT05074524 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Transcranial Magnetic Stimulation, Craving, Heroin Abuse.
What interventions are being tested in trial NCT05074524?
The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (DEVICE), Sham Repetitive Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05074524?
This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05074524 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05074524's enrollment target sits among peer trials
24 222nd of 257 higher than 31 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI